Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label, Chronic Exposure Evaluation of the Safety of CLONICEL (Clonidine HCl Sustained Release) in the Treatment of Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)

NCT00723190 is registered in ClinicalTrials.gov with Shionogi as lead sponsor.

NCT NCT00723190
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00723190 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label, Chronic Exposure Evaluation of the Safety of CLONICEL (Clonidine HCl Sustained Release) in the Treatment of Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Lead sponsor
Shionogi
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2008
Completion date
June 30, 2010
Enrollment
303 (actual)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

attention deficit hyperactivity disorder